Teshome M - Search Results

1

Absence of lobular carcinoma in situ is a poor prognostic marker in invasive lobular carcinoma.

Mouabbi JA, Raghavendra AS, Bassett RL Jr, Christgen M, Middleton L, Teshome M, Nasrazadani A, Hortobagyi G, Hassan A, Tripathy D, Layman RM. Mouabbi JA, et al. Among authors: teshome m. Eur J Cancer. 2023 Sep;191:113250. doi: 10.1016/j.ejca.2023.113250. Epub 2023 Jul 22. Eur J Cancer. 2023. PMID: 37573674 Free PMC article.

2

Early, intermediate, and late effects of a surgical skills "boot camp" on an objective structured assessment of technical skills: a randomized controlled study.

Parent RJ, Plerhoples TA, Long EE, Zimmer DM, Teshome M, Mohr CJ, Ly DP, Hernandez-Boussard T, Curet MJ, Dutta S. Parent RJ, et al. Among authors: teshome m. J Am Coll Surg. 2010 Jun;210(6):984-9. doi: 10.1016/j.jamcollsurg.2010.03.006. J Am Coll Surg. 2010. PMID: 20510808 Clinical Trial.

3

The utility of endovascular simulation to improve technical performance and stimulate continued interest of preclinical medical students in vascular surgery.

Lee JT, Qiu M, Teshome M, Raghavan SS, Tedesco MM, Dalman RL. Lee JT, et al. Among authors: teshome m. J Surg Educ. 2009 Nov-Dec;66(6):367-73. doi: 10.1016/j.jsurg.2009.06.002. J Surg Educ. 2009. PMID: 20142137

4

A survey of demographics, motivations, and backgrounds among applicants to the integrated 0 + 5 vascular surgery residency.

Lee JT, Teshome M, de Virgilio C, Ishaque B, Qiu M, Dalman RL. Lee JT, et al. Among authors: teshome m. J Vasc Surg. 2010 Feb;51(2):496-502; discussion 502-3. doi: 10.1016/j.jvs.2009.08.076. J Vasc Surg. 2010. PMID: 20022205 Free article.

5

Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy.

FitzSullivan E, Bassett RL, Kuerer HM, Mittendorf EA, Yi M, Hunt KK, Babiera GV, Caudle AS, Black DM, Bedrosian I, Reyna C, Teshome M, Meric-Bernstam F, Hwang R. FitzSullivan E, et al. Among authors: teshome m. Ann Surg Oncol. 2017 Mar;24(3):652-659. doi: 10.1245/s10434-016-5605-5. Epub 2016 Oct 3. Ann Surg Oncol. 2017. PMID: 27822630 Free PMC article.

6

OncotypeDX Recurrence Score Does Not Predict Nodal Burden in Clinically Node Negative Breast Cancer Patients.

Tevis SE, Bassett R, Bedrosian I, Barcenas CH, Black DM, Caudle AS, DeSnyder SM, Fitzsullivan E, Hunt KK, Kuerer HM, Lucci A, Meric-Bernstam F, Mittendorf EA, Park K, Teshome M, Thompson AM, Hwang RF. Tevis SE, et al. Among authors: teshome m. Ann Surg Oncol. 2019 Mar;26(3):815-820. doi: 10.1245/s10434-018-7059-4. Epub 2018 Dec 17. Ann Surg Oncol. 2019. PMID: 30556120

7

Long-term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement.

Cobb AN, Diao K, Teshome M, Lucci A, Ueno NT, Stauder M, Layman RM, Kuerer HM, Woodward WA, Sun SX. Cobb AN, et al. Among authors: teshome m. Ann Surg Oncol. 2022 Oct;29(10):6381-6392. doi: 10.1245/s10434-022-12144-5. Epub 2022 Jul 14. Ann Surg Oncol. 2022. PMID: 35834145

8

[No title available]

[No authors listed] [No authors listed] PMID: 36104531

9

Targeting chemotherapy resistance in mesenchymal triple-negative breast cancer: a phase II trial of neoadjuvant angiogenic and mTOR inhibition with chemotherapy.

Abuhadra N, Sun R, Bassett RL Jr, Huo L, Chang JT, Teshome M, Clayborn AR, White JB, Ravenberg EE, Adrada BE, Candelaria RP, Yang W, Ding Q, Symmans WF, Arun B, Damodaran S, Koenig KB, Layman RM, Lim B, Litton JK, Thompson A, Ueno NT, Piwnica-Worms H, Hortobagyi GN, Valero V, Tripathy D, Rauch GM, Moulder S, Yam C. Abuhadra N, et al. Among authors: teshome m. Invest New Drugs. 2023 Jun;41(3):391-401. doi: 10.1007/s10637-023-01357-4. Epub 2023 Apr 12. Invest New Drugs. 2023. PMID: 37043123 Clinical Trial. No abstract available.

10

To Dissect or Not to Dissect: Can We Predict the Presence of Four or More Axillary Lymph Node Metastases in Postmenopausal Women with Clinically Node-Negative Breast Cancer?

Farley C, Bassett R, Meric-Bernstam F, Bedrosian I, Caudle A, DeSnyder S, Hunt K, Kuerer H, Singh P, Sun S, Tamirisa N, Teshome M, Hwang RF. Farley C, et al. Among authors: teshome m. Ann Surg Oncol. 2023 Dec;30(13):8327-8334. doi: 10.1245/s10434-023-14245-1. Epub 2023 Sep 5. Ann Surg Oncol. 2023. PMID: 37670121

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters